LXRX

Lexicon Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality5/10
  • Growth↑ 8/10
  • Momentum↑ 8/10
Lexicon Pharmaceuticals sales and earnings growth
LXRX Growth
Good
  • Revenue Y/Y↑ 1255.21%
  • EPS Y/Y↑ 74.67%
  • FCF Y/Y↑ 65.17%
Lexicon Pharmaceuticals gross and profit margin trends
LXRX Profitability
Neutral
  • Gross margin ↑ 99.40%
  • EPS margin↓ -96.80%
  • ROIC↓ -33.80%
Lexicon Pharmaceuticals net debt vs free cash flow
LXRX Risk
Great
  • Debt / Equity↓ 0.5
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -5.7

Lexicon Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗